THE EFFECT OF ADJUVANT CHEMOTHERAPY ON RELAPSE-FREE SURVIVAL IN PATIENTS WITH OSTEOSARCOMA OF THE EXTREMITY

被引：926

作者：

LINK, MP

GOORIN, AM

MISER, AW

GREEN, AA

PRATT, CB

BELASCO, JB

PRITCHARD, J

MALPAS, JS

BAKER, AR

KIRKPATRICK, JA

AYALA, AG

SHUSTER, JJ

ABELSON, HT

SIMONE, JV

VIETTI, TJ

机构：

[1] STANFORD UNIV,MED CTR,STANFORD,CA 94305

[2] CHILDRENS HOSP MED CTR,BOSTON,MA 02115

[3] HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115

[4] NCI,PEDIAT ONCOL BRANCH,BETHESDA,MD 20205

[5] NCI,SURG BRANCH,BETHESDA,MD 20205

[6] ST JUDE CHILDRENS RES HOSP,MEMPHIS,TN 38101

[7] ST BARTHOLOMEWS HOSP,LONDON EC1A 7BE,ENGLAND

[8] CHILDRENS HOSP,PHILADELPHIA,PA 19104

[9] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77030

[10] PEDIAT ONCOL GRP,STAT OFF,GAINESVILLE,FL

[11] WASHINGTON UNIV,MED CTR,ST LOUIS,MO 63130

来源：

关键词：

D O I：

10.1056/NEJM198606193142502

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1600 / 1606

页数：7

共 31 条

[21] SURVIVAL FOLLOWING AGGRESSIVE RESECTION OF PULMONARY METASTASES FROM OSTEOGENIC-SARCOMA - ANALYSIS OF PROGNOSTIC FACTORS
PUTNAM, JB
ROTH, JA
WESLEY, MN
JOHNSTON, MR
ROSENBERG, SA
[J]. ANNALS OF THORACIC SURGERY, 1983, 36 (05) : 516 - 523
[22] ROSEN G, 1975, CANCER-AM CANCER SOC, V35, P936, DOI 10.1002/1097-0142(197503)35:3+<936::AID-CNCR2820350714>3.0.CO
[23] 2-B
[24] PRIMARY OSTEOGENIC-SARCOMA - 8-YEAR EXPERIENCE WITH ADJUVANT CHEMOTHERAPY
ROSEN, G
MARCOVE, RC
HUVOS, AG
CAPARROS, BI
LANE, JM
NIRENBERG, A
CACAVIO, A
GROSHEN, S
[J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 : 55 - 67
[25] ROSENBERG SA, 1979, CANCER TREAT REP, V63, P739
[26] SUTOW WW, 1975, CANCER-AM CANCER SOC, V36, P1598, DOI 10.1002/1097-0142(197511)36:5<1598::AID-CNCR2820360511>3.0.CO
[27] 2-N
[28] TRENDS AND VARIABILITY IN SURVIVAL AMONG PATIENTS WITH OSTEO-SARCOMA - A 7-YEAR UPDATE
TAYLOR, WF
IVINS, JC
PRITCHARD, DJ
DAHLIN, DC
GILCHRIST, GS
EDMONSON, JH
[J]. MAYO CLINIC PROCEEDINGS, 1985, 60 (02) : 91 - 104
[29] TAYLOR WF, 1978, MAYO CLIN PROC, V53, P695
[30] TAYLOR WF, 1978, IMMUNOTHERAPY CANCER, P257